Mead Johnson & Company (Enfamil)
Premature Infants Given Enfamil? NEC Lawsuits Are Underway
Families claim Mead Johnson's cow's-milk-based Enfamil formulas may raise the risk of necrotizing enterocolitis in premature or low-birth-weight infants and that warnings fell short. One Illinois jury awarded $60 million in a related death case, but there's still no nationwide settlement for affected families to join.
Key facts
- Claim deadline
- No deadline listed
- Potential payment
- Payment varies
- Proof listed
- No proof requirement listed
- Status
- Upcoming
Plain-language overview
Who may qualify?
Eligibility depends on the dates, products, locations, and other terms listed for this claim. Review any criteria below and the official terms before deciding whether it may apply to you.
- Premature or low‑birth‑weight infant: The child was preterm or low birth weight.
- Cow’s‑milk Enfamil exposure: The child consumed Enfamil or other cow’s‑milk‑based formula/fortifier, typically identified in NICU feeding orders or formula records.
- Documented NEC diagnosis: The child has a medical diagnosis of necrotizing enterocolitis (NEC) in NICU/hospital medical records, often with imaging or surgical notes. (https://www.drugwatch.com/baby-formula/lawsuits/enfamil/)
- NEC linked to formula feeding period: The NEC diagnosis occurred during or after hospital/NICU formula feeding or formula feeding post‑discharge, not from an unrelated later cause.
Case overview
What this settlement is about
Parents of premature or low-birth-weight babies allege that Enfamil formulas made from cow's milk may increase the risk of necrotizing enterocolitis (NEC), a serious intestinal disease, and that Mead Johnson failed to adequately warn parents and doctors about the potential danger. The claims have already produced one major result: an Illinois state court jury awarded $60 million to a mother whose infant died from NEC after being given Enfamil. Beyond that case, hundreds of similar Enfamil claims are consolidated in ongoing federal litigation known as MDL 3026, based in the Northern District of Illinois, where they proceed alongside comparable cases against other formula makers. Despite this activity, no nationwide settlement, payout structure, or court-approved claims program has been established yet. That means there's no standard process for filing a claim right now — families seeking compensation must currently pursue individual lawsuits, backed by medical records and documentation of product use, rather than relying on a unified settlement.
